ValueDo Life Sciences Consulting, partner to over 20 global pharmaceutical companies across 25 markets, today announced the full-scale launch of JAWAAB™, its Agentic AI-powered engagement platform built to modernize how biopharma connects with healthcare professionals (HCPs).

Initially introduced with a top-three U.S. pharma, JAWAAB™ is already live with 10,000+ HCPs, earning strong praise for its intuitive, human-like experience from both academic and community physicians. The platform was also featured at SGO 2025, where leading oncologists highlighted its potential to redefine Medical and Commercial omnichannel engagement standards.

Humanized AI, Purpose-Built for Pharma

JAWAAB™ combines Agentic AI-ML and advanced NLP to deliver one of the industry’s first fully compliant, personalized conversational platforms for HCPs and patients.

Key capabilities include:

• Multi-level personalization
• Off-label question workflows
• Automated AE reporting
• Peer-to-peer scientific content sharing
• Custom dashboards and insight analytics

These features allow pharma teams to scale credible, scientifically rich, humanized interactions far beyond static websites, legacy chatbots, or traditional NPP.

Compliance, Accuracy & Safety at the Core

JAWAAB™ operates under rigorous MLR, Compliance, AI Governance, Patient Safety, Privacy, and Technology standards, ensuring scientific accuracy and zero hallucinations.

The platform meets HIPAA, SOC 2, and global privacy requirements, with a utility patent pending for its underlying architecture.

Built for Omnichannel Integration

With expanding integrations into CRM systems, marketing automation, and enterprise omnichannel ecosystems, JAWAAB™ complements both personal and non-personal promotion, helping biopharma deliver credible scientific exchange at scale while strengthening trust and compliance.

“JAWAAB™ isn’t just another digital tool, it represents the next era of compliant, AI-powered engagement,” said ValueDo leadership. “Our goal is simple: help biopharma deliver humanized, trusted, on-demand scientific interactions that matter.”

Pharma organizations interested in exploring JAWAAB™ can contact info@jawaab.ai or visit www.jawaab.ai.

ValueDo recently joined NASDAQ Trade Talks to discuss the future of trusted, compliant AI in biopharma: https://www.nasdaq.com/videos/how-legislative-priorities-regulatory-frameworks-and-strategies-are-driving-us

View source version on businesswire.com: https://www.businesswire.com/news/home/20251216535244/en/